864684-80-0 Usage
Uses
Used in Pharmaceutical Industry:
(4-METHYL-PYRIDIN-2-YLOXY)-ACETIC ACID ETHYL ESTER is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structure and properties make it a valuable component in the development of new drugs and medications.
Used in Agricultural Industry:
(4-METHYL-PYRIDIN-2-YLOXY)-ACETIC ACID ETHYL ESTER is used as a starting material for the development of new herbicides. Its potential application in this area is currently under investigation, with the aim of creating more effective and environmentally friendly solutions for weed control.
Used in Chemical Synthesis:
(4-METHYL-PYRIDIN-2-YLOXY)-ACETIC ACID ETHYL ESTER is used as an intermediate in the synthesis of a wide range of chemical products. Its versatile nature allows it to be a key component in the production of various commercial products, contributing to its importance in the chemical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 864684-80-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,6,8 and 4 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 864684-80:
(8*8)+(7*6)+(6*4)+(5*6)+(4*8)+(3*4)+(2*8)+(1*0)=220
220 % 10 = 0
So 864684-80-0 is a valid CAS Registry Number.
864684-80-0Relevant academic research and scientific papers
Synthesis, structure analysis, DFT calculations and energy frameworks of new coumarin appended oxadiazoles, to regress ascites malignancy by targeting VEGF mediated angiogenesis
Banumathi,Jyothi, Mahima,Khamees, Hussien Ahmed,Khanum, Shaukath Ara,Prabhakar, B. T.,Sherapura, Ankith,Zabiulla
, (2021/12/24)
Ascites malignancy is a frequent cause of morbidity and presents significant management problems which occur in many cancers. Angiogenesis plays a major role in the prognosis of ascites tumor through Vascular Endothelial Growth Factor (VEGF). Inhibition o
QUINOLINONE DERIVATIVES
-
Page/Page column 53, (2012/09/22)
The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.
